409 related articles for article (PubMed ID: 4979333)
1. [On the demonstration of Bence Jones proteins].
Morell A; Gerber H; Lopez V; Barandun S
Schweiz Med Wochenschr; 1969 Jun; 99(24):876-85 contd. PubMed ID: 4979333
[No Abstract] [Full Text] [Related]
2. [On the detection of Bence Jones proteins].
Morell A; Gerber H; Lopez V; Barandun S
Schweiz Med Wochenschr; 1969 Jun; 99(25):920-4. PubMed ID: 4980183
[No Abstract] [Full Text] [Related]
3. Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia.
Dammacco F; Waldenström J
Clin Exp Immunol; 1968 Nov; 3(9):911-21. PubMed ID: 4180117
[TBL] [Abstract][Full Text] [Related]
4. On the demonstration of Bence Jones proteinuria.
Mörstad KS
Acta Med Scand; 1967 Oct; 182(4):457-63. PubMed ID: 4964178
[No Abstract] [Full Text] [Related]
5. [Principal symptom "paraproteinemia"].
Scheiffarth F; Götz H
Med Klin; 1970 Jun; 65(25):1221-8. PubMed ID: 4102908
[No Abstract] [Full Text] [Related]
6. Anomalous urinary proteins in patients with serum M-components.
Pruzanski W; Ogryzlo MA
Can Med Assoc J; 1971 Apr; 104(7):581-8. PubMed ID: 4994475
[TBL] [Abstract][Full Text] [Related]
7. [The "minor" paraproteinemias].
Melini L; Marani L; Bergamini A
Acta Gerontol (Milano); 1967; 17(4):221-37. PubMed ID: 4179190
[No Abstract] [Full Text] [Related]
8. Bence-Jones proteins and light chains of immunoglobulins (second of two parts).
Solomon A
N Engl J Med; 1976 Jan; 294(2):91-8. PubMed ID: 53788
[No Abstract] [Full Text] [Related]
9. [Clinical significance of Bence Jones protein analysis in biochemical laboratory tests].
Arakawa M
Nihon Rinsho; 1989 Dec; 48 Suppl():158-60. PubMed ID: 2516150
[No Abstract] [Full Text] [Related]
10. IV. Detection and differentiation of M-proteins by the acid-gel reaction--a re-evaluation.
Daniels JC; Cobb EK; Levin WC; Ritzmann SE
Tex Rep Biol Med; 1970; 28(4):541-5. PubMed ID: 4995465
[No Abstract] [Full Text] [Related]
11. Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics.
Dammacco F; Waldenström J
Acta Med Scand; 1968 Nov; 184(5):403-9. PubMed ID: 4184003
[No Abstract] [Full Text] [Related]
12. Specific analysis of immunoglobulins. Techniques and clinical value.
Heremans JF; Masson PL
Clin Chem; 1973 Mar; 19(3):294-300. PubMed ID: 4631905
[No Abstract] [Full Text] [Related]
13. Proteinuria in multiple myeloma and related diseases.
Ganeval D; Lacour B; Chopin N; Grünfeld JP
Am J Nephrol; 1990; 10 Suppl 1():58-62. PubMed ID: 2124083
[TBL] [Abstract][Full Text] [Related]
14. [Bence-Jones cryoprotein in a patient with multiple myeloma].
Zlotnick A; Ben-Chetrit E; Eilat D
Harefuah; 1982 Sep; 103(5-6):91-3. PubMed ID: 7169179
[No Abstract] [Full Text] [Related]
15. [Hypolipidemia in myeloma].
Fiessinger JN; Ollier MP; Filitti-Wurmser S; Hartmann L
Ann Biol Clin (Paris); 1971; 29(1):25-37. PubMed ID: 4996178
[No Abstract] [Full Text] [Related]
16. [Dysproteinemic plasmacytomiatic diseases from the gerontologic viewpoint].
Di Guglielmo R; Guidi G
G Gerontol; 1968 Oct; 16(10):1119-31. PubMed ID: 4980444
[No Abstract] [Full Text] [Related]
17. [Principal characteristics of heavy chain diseases].
Seligmann M
Bull Cancer; 1972; 59(4):381-8. PubMed ID: 4201934
[No Abstract] [Full Text] [Related]
18. [Hypervolemia in dysproteinemia].
Piguet H; Courtois H; Levillain M; Deshayes
Rev Rhum Mal Osteoartic; 1971; 38(8):545-7. PubMed ID: 5003549
[No Abstract] [Full Text] [Related]
19. Detection and diagnosis of monoclonal gammopathy.
Sleeper CA; Cawley LP
Am J Clin Pathol; 1969 Mar; 51(3):395-400. PubMed ID: 4179489
[No Abstract] [Full Text] [Related]
20. [Contribution to the study of the relationships between the chains of gamma-G immunoglobulins and Bence-Jones proteins].
Boffa GA; Zakin MM; Faure A; Fine JM
Transfusion (Paris); 1967; 10(2):169-81. PubMed ID: 4168874
[No Abstract] [Full Text] [Related]
[Next] [New Search]